RYBP inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Ring1 and YY1 Binding Protein (RYBP), a critical component of the Polycomb repressive complex 1 (PRC1). RYBP plays a pivotal role in epigenetic regulation by modulating the activity of PRC1, which is essential for maintaining transcriptional repression of various genes, particularly during development and differentiation. RYBP enhances the activity of PRC1 by promoting its ability to mono-ubiquitinate histone H2A at lysine 119 (H2AK119ub), a key epigenetic mark associated with gene silencing. Additionally, RYBP can interact with other proteins such as the transcription factor YY1, influencing a wide range of cellular processes, including chromatin remodeling, DNA repair, and apoptosis. By inhibiting RYBP, researchers can disrupt these regulatory mechanisms, offering a powerful tool to study the specific roles of RYBP in chromatin dynamics and gene expression.
In research, RYBP inhibitors are valuable tools for exploring the intricate mechanisms by which RYBP and PRC1 regulate gene expression and maintain epigenetic landscapes. By blocking RYBP activity, scientists can investigate how the inhibition affects PRC1's ability to modify chromatin and repress gene transcription. This inhibition allows researchers to study the downstream effects on gene expression profiles, particularly focusing on genes that are critical for developmental processes and cellular differentiation. Additionally, RYBP inhibitors provide insights into the broader networks of protein-protein interactions involved in epigenetic regulation, shedding light on the complex coordination between different components of the Polycomb group proteins and other chromatin modifiers. Through these studies, the use of RYBP inhibitors enhances our understanding of the molecular mechanisms underlying epigenetic control, the role of RYBP in maintaining transcriptional repression, and the broader implications of these processes in development, differentiation, and cellular identity.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can indirectly influence RYBP by affecting protein degradation pathways. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound is a DNA methyltransferase inhibitor that can indirectly influence RYBP function by altering DNA methylation patterns. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that could potentially influence RYBP's role in chromatin remodeling. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid is a histone deacetylase inhibitor that could potentially influence RYBP's role in chromatin remodeling. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin is a histone deacetylase inhibitor that could potentially influence RYBP's role in chromatin remodeling. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid is a histone deacetylase inhibitor that could potentially influence RYBP's role in chromatin remodeling. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A is a DNA-binding agent that can potentially influence gene expression levels of RYBP. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D is an agent that inhibits DNA transcription, thus indirectly affecting RYBP's role in gene expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide is a topoisomerase II inhibitor that could potentially influence DNA topology and indirectly affect RYBP's role. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin is a topoisomerase I inhibitor that could potentially influence DNA topology and indirectly affect RYBP's role. | ||||||